By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Ideon Science Park
Solvegatan 41
Lund    SE-22370  Sweden
Phone: 46-46-2865730 Fax: 46-46-2865739



Drug Delivery

Company News
Braeburn Pharma And Camurus Enroll First Patients In A Phase 3 Efficacy Trial Of CAM2038 For Treatment Of Chronic Low Back Pain 9/30/2016 6:45:22 AM
Camurus: Interim Report January-June 2016 7/14/2016 10:46:20 AM
Camurus Interim Report January-March 2016 5/17/2016 11:21:10 AM
Braeburn Pharma, Camurus Announce Positive Mid-Stage CAM2038 Data in Patients With Opioid Use Disorder 5/11/2016 6:02:32 AM
Camurus: Resolutions At The Annual General Meeting 2016 In Camurus 5/4/2016 11:12:22 AM
Camurus: Distribution Agreement Signed With R-PHARM US For Episil 4/21/2016 11:01:06 AM
Braeburn Pharma And Camurus Announce Enrollment Goals Reached In Two Pivotal Phase 3 Trials Of CAM2038 For Treatment Of Opioid Dependence 4/5/2016 8:29:16 AM
Notice Of Annual General Meeting 2016 And Proposal For New Incentive Program In Camurus (publ) 3/30/2016 10:46:31 AM
Camurus Annual Report For 2015 Released 3/30/2016 9:04:27 AM
Camurus: Braeburn Pharma And Camurus Announce Initiation Of A Phase 2 Study In Opioid Dependent Patients With Moderate To Severe Chronic Pain 2/22/2016 12:58:42 PM